Dr. David L. Becton
Claim this profileArkansas Children's Hospital
Expert in Cancer
Expert in Childhood Cancer
67 reported clinical trials
115 drugs studied
About David L. Becton
Education:
- Earned a Medical degree (MD) from the University of Arkansas for Medical Sciences (UAMS).
- Completed Residency in Pediatrics at Arkansas Children's Hospital.
- Undertook a Fellowship in Pediatric Cardiology at Arkansas Children's Hospital.
Experience:
- Currently serving as a pediatric cardiologist at Arkansas Children's Hospital.
Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Childhood Cancer
Global LeaderPhiladelphia chromosome positive
NTRK1 positive
NTRK positive
Affiliated Hospitals
Clinical Trials David L. Becton is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about David L. Becton
Clinical Trial Related7 years of experience running clinical trials · Led 67 trials as a Principal Investigator · 31 Active Clinical TrialsTreatments David L. Becton has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Laboratory Biomarker Analysis
- Doxorubicin Hydrochloride
- Nivolumab
Breakdown of trials David L. Becton has run
Cancer
Childhood Cancer
Lymphoma
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David L. Becton specialize in?
David L. Becton focuses on Cancer and Childhood Cancer. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage IV.
Is David L. Becton currently recruiting for clinical trials?
Yes, David L. Becton is currently recruiting for 25 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that David L. Becton has studied deeply?
Yes, David L. Becton has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with David L. Becton?
Apply for one of the trials that David L. Becton is conducting.
What is the office address of David L. Becton?
The office of David L. Becton is located at: Arkansas Children's Hospital, Little Rock, Arkansas 72202-3591 United States. This is the address for their practice at the Arkansas Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.